Posts

Combining Freshly Isolated Adipose-derived Cells With Regenogel-OSP

Nathan Katz, MSc, Ph.D., Jointechlabs, Inc., USAAvner Yayun, MD, Ph.D., Procore Biomed, Israel Procore Biomed has developed a hyaluronic-acid – plasma cross-linked hydrogel “RegenoGel” suitable for the growth and differentiation of skeletal tissue stem and progenitor cells. Jointechlabs has provided adipose-derived cell fraction obtained by the “Mini-Stem System”, which contains a range of 2-8% of […]

Short Review: Non-cultured Adipose-derived MSCs for Treatment of OA, Jointechlabs, Inc.

Treating patients with OA presents a significant challenge for physicians as no therapies to date have demonstrated efficacy in curing or even halting disease progression. Therefore, most approaches initially target pain management and factors that may be exacerbating stress on the joint. https://dx.doi.org/10.2147%2FSCCAA.S68073 – Mayo Clinic, MN Corticosteroid toxicity for chondrocytes has been long reported, both […]

Comparison of Different Conditions for the Survival of Human Abdominal Fat in vitro

Katz, N., Koukharenko, V. and Geldner, P2,3. Laboratory of Stem cells and Bioengineering, Jointechlabs, Inc., Skokie, IL North Michigan Surgical Center, Chicago, IL Geldner Center, Chicago, IL Introduction: Fat auto graft transplantation method for different reconstructive plastic surgeries has been fueled recently by encouraging reports from Japan, the United Kingdom, the United States, and others. […]

Regenerative Medicine: The Field Has Come a Long Way and Now is Having its Moment

Jointechlabs Launches MiniTC for Point-of-Care Fat Tissue Processing The scientific community has regarded regeneration as a topic of interest for thousands of years. Long before it was dubbed ‘Regenerative Medicine’, this type of medical intervention was applauded by healthcare professionals for its successful outcomes. Early discoveries, such as skin graft procedures for facial reconstructions, have […]

FDA Clears Jointechlabs’ MiniTC for Point-of-Care Fat Tissue Processing and its Broad Range of Applications

Jointechlabs – a leader in point-of-care regenerative medicine therapies – today announced that the U.S. Food and Drug Administration (FDA) cleared the company’s MiniTCTM for point-of-care fat tissue processing designed to obtain microfat (or fat grafts), for multiple indications. Jointechlabs plans to focus on a range of therapeutic areas including medical aesthetics, plastic surgery, orthobiologics […]